Why Vaxxinity (VAXX) Shares Are Down Nearly 50%
Why Vaxxinity (VAXX) Shares Are Down Nearly 50%
Vaxxinity Inc (NASDAQ:VAXX) shares are trading lower by 47% to $0.25 during Monday's session after the company announced its intention to voluntarily delist and deregister its Class A common stock.
Vaxxinity Inc（納斯達克股票代碼：VAXX）股價在週一的交易中下跌了47％，至0.25美元，此前該公司宣佈打算自願退市並註銷其A類普通股。
This decision follows non-compliance with Nasdaq's minimum bid price requirement and aims to address low trading value and volume, which hinder the company's ability to raise capital and attract investor interest. By delisting and deregistering, Vaxxinity intends to focus resources on research and development efforts without the distraction of stock price fluctuations.
該決定是在不遵守納斯達克的最低出價要求之後做出的，旨在解決交易價值和交易量低的問題，這阻礙了公司籌集資金和吸引投資者興趣的能力。通過退市和註銷註冊，Vaxxinity打算將資源集中在研發工作上，而不會受到股價波動的干擾。
The delisting is expected to take effect around May 9, with potential trading on over-the-counter markets afterward. The company plans to file necessary forms with the SEC to formalize these changes and suspend reporting obligations.
退市預計將於5月9日左右生效，之後可能會在場外市場進行交易。該公司計劃向美國證券交易委員會提交必要的表格，以正式確定這些變更並暫停報告義務。
According to data from Benzinga Pro, VAXX has a 52-week high of $3.10 and a 52-week low of $0.19.
根據Benzinga Pro的數據，VAXX的52周高點爲3.10美元，52周低點爲0.19美元。
譯文內容由第三人軟體翻譯。